Nerve-Mapping device aims to reduce side effects of rectal cancer surgery

NCT ID NCT04949646

Recruiting now Symptom relief Sponsor: Larissa University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a device that maps pelvic nerves during rectal cancer surgery. The goal is to help surgeons avoid damaging nerves that control bladder, bowel, and sexual function. About 44 adults with rectal cancer will be monitored during surgery and followed for three months to see if their quality of life improves.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pelvic intraoperative neuromonitoring (pIONM) device
What this could lead to: If it works, this could help preserve bladder, bowel, and sexual function after rectal cancer surgery, improving patients' quality of life.
What could go wrong: This is a small, early-stage study with only 44 participants, so results may not apply to everyone. The monitoring device may not reliably prevent nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rectal cancer rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RECTAL NEOPLASMS

Contacts and locations

Locations

University Hospital of Larissa
RECRUITING

Larissa, 41110, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.